Why the study?
Is enhanced intracellular signal transduction more prevalent in lymphoblasts from patients with essential hypertension compared to normotensive subjects?
Is enhanced intracellular signal transduction more prevalent in lymphoblasts from patients with essential hypertension compared to normotensive subjects?
Enhanced intracellular signal transduction, as measured by calcium responses to PAF, is significantly more prevalent in cells from patients with essential hypertension, suggesting a potential primary cellular defect.
OBJECTIVE: To determine the prevalence of enhanced signal transduction in immortalized B lymphoblasts from normotensive subjects and patients with essential hypertension. METHODS: We established Epstein-Barr virus-immortalized lymphoblast cell lines from 26 normotensive and 37 hypertensive subjects. Subsequently, we quantified rises in the cytosolic free Ca2+ concentration, [Ca2+]i, evoked by 0.1 micromol/l platelet-activating factor (PAF) in Fura-2-loaded cells. RESULTS: PAF-induced [Ca2+]i rises were independent of donor age in cells from normotensive and hypertensive subjects. Baseline values of [Ca2+]i were not significantly different in the two groups. Using the mean + 2SD of the PAF-evoked rises in [Ca2+]i above basal (110 nmol/l) as the upper normal value, we estimate that enhanced [Ca2+]i rises are distinctly more prevalent in hypertensive subjects (27%) than they are in normotensive subjects (4%). Similarly, upon definition of normal values by the 99% confidence interval (75 nmol/l), 19% of cells from normotensive versus 43% from hypertensive subjects display enhanced intracellular signaling. CONCLUSION: Enhanced intracellular signal transduction could be the primary defect in approximately one-third of the overall population with essential hypertension.
No takes yet. Share an insight, caveat, or question.
Gruska et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: